🇺🇸 FDA
Patent

US 11634452

Compounds for treating neurodegenerative disorders

granted A61PA61P25/28

Quick answer

US patent 11634452 (Compounds for treating neurodegenerative disorders) held by ETHNODYNE expires Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ETHNODYNE
Grant date
Tue Apr 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61P, A61P25/28